Antihyperglycemic Medications and Impact on Cardiovascular Outcomes: A Review of Current Evidence-Reference-Cited by-同舟云学术

Antihyperglycemic Medications and Impact on Cardiovascular Outcomes: A Review of Current Evidence

Published:2018-06-26 Issue:7 Volume:38 Page:739-757
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Gale Stormi E.¹^ORCID,Poon Jeannie L.²,Watson Kristin¹

Affiliation:

1. University of Maryland School of Pharmacy; Baltimore Maryland

2. Novant Health Presbyterian Medical Center; Charlotte North Carolina

Publisher

Wiley

Subject

Pharmacology (medical)

Reference56 articles.

1. Heart disease and stroke statistics-2018 update: a report from the American Heart Association;Benjamin;Circulation,2018

2. Effect of Rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes;Nissen;N Engl J Med,2007

3. U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research Guidance for industry: diabetes mellitus-evaluating cardiovascular risk in new antidiabetic therapies to treat type 2 diabetes http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm071627.pdf

4. Standards of medical care in diabetes;American Diabetes Association;Diabetes Care,2018

5. Consensus statement by the American association of clinical endocrinologists and American college of endocrinology on the comprehensive type 2 diabetes management algorithm - 2018 executive summary;Garber;Endocr Pract,2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Sodium-Glucose Cotransporter-2 Inhibitor Use in an Underserved Ambulatory Care Population With Type 2 Diabetes;ADCES in Practice;2021-11-22

2. Management of noncardiovascular comorbidities in patients with heart failure with reduced ejection fraction;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2021-04-29

3. Risk Reduction to Disease Management: Clinical Pharmacists as Cardiovascular Care Providers;Current Problems in Cardiology;2019-09